CurrentRheuma
Get Weekly

Topic · page 19 of 40

Rheumatoid arthritis

Early and established rheumatoid arthritis in adults: diagnosis and prediction (clinically suspect arthralgia, people at risk), treat-to-target, conventional, biologic and targeted synthetic drugs, tapering and withdrawal, glucocorticoids, extra-articular disease and rheumatoid arthritis–associated interstitial lung disease

Briefs 721–760 of 1,564 placed here, newest publication first

Briefs in Rheumatoid arthritis

Newest publication first

  1. Rheumatology (Oxford)

    Comparative effects of biological and targeted synthetic DMARDs on incident chronic kidney disease in patients with rheumatoid arthritis

    Cohort study

  2. Scand J Rheumatol

    Remote patient-reported outcome measure triage score for monitoring disease activity and allocation of consultations in rheumatoid arthritis patients

    Cross-sectional study

  3. Rheumatology (Oxford)

    High serum levels of CXCL13 predict lower response to csDMARDs in both ACPA-positive and ACPA-negative early rheumatoid arthritis

    Cohort study

  4. RMD Open

    Disease response in rheumatoid arthritis across four biologic therapies associates with improvement in paraoxonase-1 activity and oxylipins

    Cohort study

  5. Semin Arthritis Rheum

    New onset work disability in rheumatoid arthritis is an underrecognized cardiovascular risk factor: A retrospective cohort study using the CorEvitas registry

    Cohort study

  6. Scand J Rheumatol

    Cohort study of serological biomarkers for interstitial lung disease in patients with rheumatoid arthritis

    Cohort study

  7. Arthritis Rheumatol

    Effectiveness of JAK Inhibitors Compared With Biologic Disease‐Modifying Antirheumatic Drugs on Pain Reduction in Rheumatoid Arthritis: Results From a Nationwide Swedish Cohort Study

    Cohort study

  8. Rheumatology (Oxford)

    Anti-peptide antibodies, anti-SNRK and anti-HUWE1 antibodies as potential predictors of good response to tofacitinib therapy in rheumatoid arthritis patients

    Diagnostic or prognostic study

  9. Scand J Rheumatol

    Risk profiles for rheumatoid arthritis-associated interstitial lung disease in a cohort of patients with five-year follow-up

    Cohort study

  10. RMD Open

    Efficacy and safety of filgotinib in patients with rheumatoid arthritis: week 156 interim results from a long-term extension study

    Research article

  11. Joint Bone Spine

    Poor prognostic factors independently impact remission and treatment escalation in rheumatoid arthritis regardless of disease activity: A nationwide prospective cohort study

    Cohort study

  12. Lancet Rheumatol

    Evaluation of proximod, a selective agonist of sphingosine-1-phosphate receptor-1, in healthy volunteers and patients with rheumatoid arthritis: a phase 1, double-blind, randomised, placebo-controlled, ascending dose trial

    Randomized controlled trial

  13. RMD Open

    Comparing outcomes of patients with early active rheumatoid arthritis initially treated on an inpatient or outpatient basis: a posthoc analysis of the CORRA trial

    Secondary analysis

  14. Ann Rheum Dis

    Olokizumab plus methotrexate: safety and efficacy over 106 weeks of treatment

    Meta-analysis

  15. RMD Open

    The effect of rituximab on patient reported outcomes in the preclinical phase of rheumatoid arthritis: 2 year data from the PRAIRI study

    Secondary analysis

  16. RMD Open

    Combining patient-reported outcome measures to screen for active disease in rheumatoid arthritis and psoriatic arthritis

    Diagnostic or prognostic study

  17. RMD Open

    Efficacy and safety of CT-P47 versus reference tocilizumab: 32-week results of a randomised, active-controlled, double-blind, phase III study in patients with rheumatoid arthritis, including 8 weeks of switching data from reference tocilizumab to CT-P47

    Randomized controlled trial

  18. Rheumatology (Oxford)

    Impact of incident rheumatoid arthritis on earnings: a nationwide sibling comparison study

    Cohort study

  19. Lancet Rheumatol

    Factors associated with biological and targeted synthetic disease-modifying antirheumatic drug initiation for rheumatoid arthritis in underserved patient groups in England and Wales, UK: a national cohort study

    Cohort study

  20. Arthritis Care Res (Hoboken)

    Impact of Sex, Serostatus, and Smoking on Risk for Rheumatoid Arthritis–Associated Interstitial Lung Disease Subtypes

    Case-control study

  21. Arthritis Care Res (Hoboken)

    Preferences for Tapering Biologic Disease‐Modifying Antirheumatic Drugs Among People With Rheumatoid Arthritis: A Discrete Choice Experiment

    Research article

  22. Rheumatology (Oxford)

    Unique transcriptomic profile of peripheral blood monocytes in rheumatoid arthritis-associated interstitial lung disease

    Mechanistic study

  23. J Rheumatol

    Disability Related to the Upper Extremities in Early Rheumatoid Arthritis – Long-term Course and Disease Parameter Impact: a cohort study

    Cohort study

  24. J Rheumatol

    Trends in Anxiety and Depression Among Individuals With Rheumatoid Arthritis: A Population-Based Study

    Cohort study

  25. Clin Exp Rheumatol

    Comparison of the efficacy of Janus kinase inhibitors and adalimumab in rheumatoid arthritis: a meta-analysis

    Meta-analysis

  26. Semin Arthritis Rheum

    The impact of cardiovascular and cerebrovascular disease on the risk of dementia in rheumatoid arthritis: A mediation analysis

    Cohort study

  27. Semin Arthritis Rheum

    Effectiveness of patient education on the quality of life of patients with rheumatoid arthritis: A systematic review and meta-analysis

    Meta-analysis

  28. Arthritis Res Ther

    Methotrexate promotes the release of granulocyte–macrophage colony-stimulating factor from rheumatoid arthritis fibroblast-like synoviocytes via autocrine interleukin-1 signaling

    Mechanistic study

  29. Semin Arthritis Rheum

    Disease-modifying antirheumatic drugs and risk of incident interstitial lung disease among patients with rheumatoid arthritis: A systematic review and meta-analysis

    Meta-analysis

  30. Joint Bone Spine

    2024 update of the recommendations of the French Society of Rheumatology for the diagnosis and management of patients with rheumatoid arthritis

    Guideline or statement

  31. Arthritis Res Ther

    Contribution of inflammation markers and quantitative sensory testing (QST) indices of central sensitisation to rheumatoid arthritis pain

    Cross-sectional study

  32. RMD Open

    Methotrexate treatment hampers induction of vaccine-specific CD4 T cell responses in patients with IMID

    Mechanistic study

  33. Semin Arthritis Rheum

    Efficacy and safety of abatacept in preclinical rheumatoid arthritis: A systematic review and meta-analysis of randomized controlled trials

    Meta-analysis

  34. RMD Open

    Forefoot inflammation in recent-onset ACPA-positive and ACPA-negative RA: clinically similar, but different in underlying inflamed tissues

    Cross-sectional study

  35. Semin Arthritis Rheum

    Cardiovascular safety of the class of JAK inhibitors or tocilizumab compared with TNF inhibitors in patients with rheumatoid arthritis: Systematic review and a traditional and Bayesian network meta-analysis of randomized clinical trials

    Meta-analysis

  36. Scand J Rheumatol

    Cost–utility analysis of longstanding exercise therapy versus usual care in people with rheumatoid arthritis and severe functional limitations

    Randomized controlled trial

  37. Arthritis Res Ther

    Low dose methotrexate impaired T cell transmigration through down-regulating CXCR4 expression in rheumatoid arthritis (RA)

    Mechanistic study

  38. Ann Rheum Dis

    Efficacy and safety of first-line biological DMARDs in rheumatoid arthritis patients with chronic kidney disease

    Cohort study

  39. Ann Rheum Dis

    Exploring the effect on primary endpoints in trials testing targeted therapy interventions for rheumatoid arthritis: a meta-epidemiological study on the appropriate use of a core outcome set

    Randomized controlled trial

  40. Clin Exp Rheumatol

    Macrophage requirements for abatacept response in rheumatoid arthritis

    Mechanistic study

All 1,564 Briefs in ExploreShowing Briefs 721–760 of 1,564, newest first